All News about Orphazyme A/S ADR![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Orphazyme Stock Gains After FDA Update On Arimoclomol In Rare Neurodegenerative Disorder
November 01, 2021
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]()
Promising New Developments Causing Some Biotech Stocks to Pull Away from Underperforming Peers
October 14, 2021
Topics
Stocks
Exposures
US Equities
![]() ![]()
Orphazyme A/S (NASDAQ:ORPH) Shareholder Notice: Deadline in Lawsuit on September 7, 2021
October 06, 2021
Via SBWire
Topics
Lawsuit
![]() Via NewMediaWire
Topics
Lawsuit
![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() Via NewMediaWire
Topics
Lawsuit
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Orphazyme A/S ADR (NQ: ORPH )All News about Orphazyme A/S ADR
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|